Added successfully to RFQ list

Added successfully to compare list

Our clients

o2h discovery is a highly reputed service provider of mg/g scale discovery chemistry. We have partnered with a range of well-known pharmaceutical and biotechnology companies from Europe, USA, and Japan to serve chemistry services and custom synthesis services.

o2h discovery, strategically positioned with its Anglo-Indian roots, adds substantial value to its collaborations. The UK-based head office and key functions, encompassing business development and project liaison, enable o2h discovery to provide high-level support for project meetings, discussions, contracts, agreements, project feedback, and response. The state-of-the-art research center in India is the hub for o2h discovery’s high-quality chemistry services, offering cost advantages such as import duty exemptions on raw materials and consumables (India site registered as an EOU). With access to a vast pool of talented staff and individuals globally, o2h discovery integrates high-quality experience into its drug discovery projects.

The specialised team at o2h discovery has a broad array of experience in preparing small-molecule NCEs (Novel Chemical Entities) with the requisite high-quality specifications. It is proficient in utilising perse methodologies, including the synthesis of singles, multi-step, small arrays as well as focused libraries. Our scientific team is also experienced in the parallel construction of focused libraries for use in hit-to-lead and lead optimisation projects.

The delivery of all our compounds is accompanied by complete characterisation data including, but not limited to, high-field NMR, mass, and purity by LC-MS/HPLC/GC.

Access to databases such as SciFinder and Beilstein provides the team with all the necessary current information to modify and develop new synthetic routes.

o2h discovery has experience in a wide range of chemistry services and custom synthesis services, including:

o2h discovery chemistry services

To know more about our chemistry services or to request our brochure, please reach out to us at discovery@o2h.com.

    our team

    Prashant Shah

    CEO - o2h discovery and Co-Founder - o2h group

    Prashant's Biography

    Read more

    Prashant Shah

    CEO - o2h discovery and Co-Founder - o2h group

    Prashant is a serial entrepreneur in life sciences and tech in which one of those companies was acquired by a public company. He is currently active in seed investing (a portfolio of ~50 companies), product/IP development, services, and building lab/office infrastructure. The early career was with the Strategy group at Accenture. He has a BEng, an MSc, in which he worked on the Human Genome Program at the Sanger Centre, and an MPhil in Management from the Judge Institute. Prashant is also a General Partner in the o2h SEIS/EIS Human Health Funds.


    Connect on linkedin

    Sunil Shah

    CEO - o2h Ventures and Co-Founder - o2h group

    Sunil's Biography

    Read more

    Sunil Shah

    CEO - o2h Ventures and Co-Founder - o2h group

    A serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector. The second of these companies, Oxygen Healthcare Ltd was acquired by Piramal Enterprises Ltd (BSE: PEL). Sunil co-founded o2h ventures which involves discovery services / collaborations, seeding drug discovery, academic in-licensing and biotechnology incubation. Sunil has a degree in Biochemistry and an MBA from Cambridge University


    Connect on linkedin

    Andy Morley

    Chief Scientific Officer

    Andy's Biography

    Read more

    Andy Morley

    Chief Scientific Officer

    Andy is a highly experienced and accomplished Medicinal Chemist with over 25 years of experience in major pharmaceutical companies such as Sanofi-Aventis and AstraZeneca. He has extensive experience across all phases of drug discovery and has played a key role in the development of five candidates that have reached clinical trials. Andy is a prolific author and inventor, with over 55 publications and patents to his name. Since 2013, he has been working full-time with o2h Limited, where he leads the scientific evaluation of investment opportunities and provides scientific support. He has also served as CSO for two early-stage collaborations within the o2h Ventures portfolio, demonstrating his ability to successfully guide drug discovery projects from concept to clinical development.


    Connect on linkedin

    David Davies - o2h

    David Davies

    Head of Medicinal Chemistry

    David's Biography

    Read more

    David Davies

    Head of Medicinal Chemistry

    David Davies has 25 years of experience in medicinal chemistry within the pharmaceutical industry with a focus on the antibacterial area (clavulanates, penicillinates, pseudomonates and bacterial topoisomerase inhibitors). He previously worked at GSK and currently holds a part-time academic position at University College London (UCL). He served as the Head of Medicinal Chemistry at Antabio for nearly a decade, specialising in antibacterial research, and has extensive experience managing chemistry projects in multiple countries including France, UK, India and China. He is the inventor of 40 patents and has authored 37 publications.


    Connect on linkedin

    o2h group launched revolutionary project management app for drug discovery

    o2h group launched revolutionary project management app for drug discovery. The app’s full suite of project management tools is available exclusively to live project collaborators and a lighter version is open for researchers looking for a quote for the synthesis of small molecules.

    the influencer biotech bootcamp

    Hauxton House, Mill Scitech Park, Cambridge

    The world’s first biotech bootcamp, including the quintet influencer community that is the creative force driving biotech.

    View more

    latest news

    Read about some of the most recent developments including research collaborations at o2h discovery

    speak to a member of our team

    Contact Us